Tight Glycemic Control, Inflammation, and the ICU: Evidence for Heterogeneous Treatment Effects in Two Randomized Controlled Trials

Am J Respir Crit Care Med. 2023 Apr 1;207(7):945-949. doi: 10.1164/rccm.202210-1988LE.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Blood Glucose*
  • Glycemic Control*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Inflammation
  • Insulin
  • Intensive Care Units
  • Randomized Controlled Trials as Topic

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin

Associated data

  • ClinicalTrials.gov/NCT01565941
  • ClinicalTrials.gov/NCT01892969
  • ClinicalTrials.gov/NCT00673309